PRKACA and cholangiocarcinoma: Kinase enrichment analysis of these 163 genes demonstrated enrichment of PRKACA substrates (Fig. 2d) suggesting that PKA activity, likely though the DNAJB1-PRKACA fusion, distinguishes FLC from both HCC and CCA.